AB
Arcutis Biotherapeutics, Inc. - Common stock
ARQT
Close · 10/09/2026
23.38
1D
-1.93%52-week range
16.57 – 31.77
Volume
17,84,900.00
Price history
ARQT
11/08/2026 to 10/09/2026
O 23.70 H 23.84 L 23.25
1W-1.97%
1M-10.87%
3M+0.65%
6M-2.38%
1Y+30.40%
3Y+182.37%
5Y+9.92%
MAX-7.95%
Fundamentals
as of 10/09/2026- Market cap
- $2.94B
- Shares out
- 125.69M
- P/E (trailing)
- 103.04
- P/E (forward)
- 18.34
- EPS (trailing)
- 0.23
- Beta
- 1.50
- Profit margin
- 6.17%
- P/B
- 13.32
- Return on equity
- 12.93%
SEC financial statements
25 quarterly and 8 annual periods through 30/06/2026.
Details
- Ticker
- ARQT
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
2 filers · 1 on watchlist · 4 buys · 2 sells · D: 6
- 29/05/2026Gilbert CisnerosBuyArcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyArcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000
- 11/12/2025Gilbert CisnerosSell+Arcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000
- 15/09/2023Josh GottheimerWSellArcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000
- 17/04/2023Josh GottheimerWBuyArcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000
- 15/06/2022Josh GottheimerWBuyArcutis Biotherapeutics, Inc. - Common stock$1,001–$15,000